Peng Zhang
8PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 18, 2025
pH-dependent dissociation from CTLA-4 in early endosomes improves both safety and antitumor activity of anti-CTLA-4 antibodies.Meiyu Zhang, Jinmei Li, Kepeng Yan
|Aug 30, 2023
A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.John Magenau, Samantha Jaglowski, Joseph Uberti
|Mar 01, 2023
Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy.Mingyue Liu, Xu Wang, Xuexiang Du
|Dec 10, 2020
Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody.Han Gao, Haiyan Cai, Jia Liu
|Mar 14, 2019
<i>MYC</i> Drives Group 3 Medulloblastoma through Transformation of Sox2<sup>+</sup> Astrocyte Progenitor Cells.Ran Tao, Najiba Murad, Zhenhua Xu
|Jan 04, 2018
An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth.Toshihiko Tanno, Peng Zhang, Christopher A Lazarski
Pageof 2
